EFA
GOSS icon

Evernest Financial Advisors’s Gossamer Bio GOSS Stock Holding History

Evernest Financial Advisors’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.41K Sell
26,769
-2,000
-7% -$558 ﹤0.01% 191
2026
Q1 		$10K Buy
28,769
+369
+1% +$580 ﹤0.01% 180
2025
Q4 		$64.2K Buy
28,400
+8,400
+42% +$24K 0.01% 183
2025
Q3 		$52.6K Buy
+20,000
New +$44.1K 0.01% 186

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Evernest Financial Advisors's GOSS Position: Q2 2026 in Review

Evernest Financial Advisors reduced its Gossamer Bio (GOSS) stake by 7% in Q2 2026, selling an estimated $558 and leaving 26,769 shares worth $4.41K. The position accounts for ﹤0.01% of the portfolio, ranked #191.

Evernest Financial Advisors first reported a position in GOSS in Q3 2025 and has held it in 4 quarters since. The position peaked at $64.2K in Q4 2025. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Evernest Financial Advisors held 26,769 shares of Gossamer Bio worth $4.41K as of Q2 2026.
  • Evernest Financial Advisors sold 2,000 Gossamer Bio shares in Q2 2026, an estimated $558.
  • Gossamer Bio made up ﹤0.01% of Evernest Financial Advisors's portfolio in Q2 2026, its #191 holding.
  • Evernest Financial Advisors first reported a position in Gossamer Bio in Q3 2025 and has held it in 4 quarters since.
  • Evernest Financial Advisors's Gossamer Bio position peaked at $64.2K in Q4 2025.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Evernest Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.